7686 J . Org. Chem., Vol. 62, No. 22, 1997
Gross et al.
400 MHz) δ 7.75 (br, 1H), 7.18-7.12 (m, 2H), 6.93 (td, J )
0.98, 7.6 Hz, 1H), 5.79-5.68 (m, 1H), 5.11-5.05 (m, 2H), 4.46
(br, 1H), 3.24 (dd, J ) 9.8, 16.1 Hz, 1H), 2.79 (dd, J ) 2.0,
16.1 Hz, 1H), 2.52 (br, 1H) 2.32-2.25 (m, 1H), 1.58 (s, 9H);
13C NMR (CDCl3, 100 MHz) δ 152.2, 140, 133.7, 130, 127.3,
124.8, 122.3, 117.9, 118.1, 82.5, 58.5, 39.0, 32.7, 28.4. Anal.
Calcd for C16H21NO2: C, 74.10; H, 8.16; N, 5.40. Found: C,
73.69; H, 8.08; N, 5.41. The enantiomers were separated on
the (S,S)-Whelk-O 1 column (0.5% IPA/hexane, 1.00 mL/
min): rt ) 10.1 (32%), 11.2 (68%).
mmol) was added a 0.10 M solution of 2 (110 µL, 0.48 mmol)
and s-BuLi (0.43 mL, 1.1 M, 0.48 mmol). After the addition
of Me3SnCl13 (1.0 M, 0.60 mL, 0.60 mmol), the solution was
stirred at -78 °C for 5 h. Following chromatographic purifica-
tion (2.5-5% EtOAc/hexane), 15.4 mg of starting material was
recovered, and (S)-15 (131.4 mg, 78%) was obtained as a
1
colorless oil: [R]25 +51° (c 0.0094, CHCl3); H NMR (CDCl3,
D
300 MHz) δ 7.14 (d, J ) 7.9 Hz, 1H), 7.07 (d, J ) 7.1 Hz, 1H),
6.94 (t, J ) 7.5 Hz, 1H), 4.22 (dd, J ) 7.0, 8.7 Hz, 1H), 3.34
(dd, J ) 8.9, 15.5 Hz, 1H), 2.89 (dd, J ) 6.8, 15.5 Hz, 1H),
1.52 (s, 9H), 0.07 (s, J (Sn-H) ) 53.1 Hz, 9H); 13
In addition, 1-(tert-butoxycarbonyl)indole31 (25.2 mg, 23%)
and 1 (28.6, 26%) were isolated from this reaction.
C NMR (CDCl3,
75 MHz) δ 153.6, 140.9, 138.5, 128.7, 124.9, 123.8, 122.4, 81.2,
53.4 (J (Sn-C) ) 388.9 Hz), 34.6, 28.1, -9.4 (J (Sn-C) ) 339.5
Hz, 324.3 Hz); HRMS calcd for C16H24ClNO2Sn (M+) 413.0513,
found 413.0513 (0.0 mDa). The enantiomers were separated
on the (R,R)-Beta-Gem column (100% hexane, 0.5 mL/min):
rt ) 7.5 (12%), 8.4 (88%).
P r ep a r a tion of En a n tiom er ica lly En r ich ed (S)-1-(ter t-
Bu toxyca r bon yl)-2-(tr im eth ylsta n n yl)in d olin e (3) a t -40
°C. To a solution of 1 (116 mg, 0.527 mmol) and 2 (160 µL,
0.69 mmol) in 5.5 mL of cumene at -40 °C was added s-BuLi
(0.53 mL, 1.3 M, 0.69 mmol). The solution stirred at -40 °C
for 1 h, and a solution of Me3SnCl13 (0.79 mL, 1.00 M, 0.79
mmol) in hexanes was added. The solution was maintained
at -40 °C for 1 h, and then the reaction was quenched with
water. The workup was as described above. Following flash
chromatography with 2% EtOAc/hexane and preparative
HPLC with 0.5% EtOAc/hexane, (S)-3 (59.3 mg, 29%) was
isolated as a colorless oil. The enantiomers were separated
by CSP HPLC using the (R,R)-Beta-Gem column (100%
hexane, 0.25 mL/min): rt ) 18.4 min (3%), 20.2 min (97%).
In addition 1 (41.9 mg, 36%) was recovered from the reaction
as well as 4 (4.4 mg, 2.2%).
Gen er a l P r oced u r e for th e Asym m etr ic Dep r oton a -
tion of 1-(ter t-Bu toxyca r bon yl)-7-ch lor oin d olin e (12). To
a solution of (-)-sparteine (2) (1.2 equiv) in MTBE was added
a solution of s-BuLi (1.2 equiv) in cyclohexane at -78 °C. The
solution was stirred for 10 min, and a precooled solution of 12
(1 equiv) in MTBE was added to the s-BuLi/(-)-sparteine. The
solution was stirred for 3.5 h, and then an excess of electrophile
(1.5 equiv) was added. After 3 h, the reaction was quenched
at -78 °C with 5 mL of 15% NH4Cl solution. The mixture
was allowed to come to room temperature slowly and stirred
overnight. The aqueous solution was then extracted with
ether (3 × 10 mL). The combined organic layers were washed
with 5 mL of brine, dried over MgSO4, filtered, and concen-
trated in vacuo. The crude products were purified by flash
chromatography. The er’s were determined by analytical CSP
HPLC.
In addition 4 (2 mg, 1%) was isolated as a white solid.
P r ep a r a tion of En a n tiom er ica lly En r ich ed (S)-1-(ter t-
Bu toxycar bon yl)-7-ch lor o-2-(tr ibu tylstan n yl)in dolin e (16).
To a 0.07 M solution of 2 (85 µL, 0.37 mmol) and s-BuLi (0.29
mL, 1.3 M, 0.37 mmol) was added a 0.03 M solution of 12 (77.9
mg, 0.307 mmol). Bu3SnCl was added, and following the
workup and chromatographic purification (2.5% EtOAc/hex-
ane), indoline (S)-16 (116 mg, 69%) was isolated as a colorless
oil: 1H NMR (CDCl3, 300 MHz) δ 7.14 (d, J ) 7.8 Hz, 1H),
7.06 (d, J ) 7.0 Hz, 1H), 6.93 (t, J ) 7.6 Hz, 1H), 4.46 (dd, J
) 4.1, 9.3 Hz, 1H), 3.51 (dd, J ) 9.4, 15.3 Hz, 1H), 2.89 (dd, J
) 4.0, 15.4 Hz, 1H), 1.53 (s, 9H), 1.40 (m, 6H), 1.25 (sextet, J
) 7.0 Hz, 6H), 0.85 (t, J ) 7.1 Hz, 9H), 0.8-0.9 (m, 6H); 13C
NMR (CDCl3, 75 MHz) δ 153.1, 140.8, 138.6, 128.7, 125.0,
124.2, 122.5, 81.0, 53.4, 35.0, 29.0, 28.2, 27.4, 13.6, 9.4. Anal.
Calcd for C25H42NO2ClSn: C, 55.32; H, 7.80; N, 2.58. Found:
C, 55.37; H, 7.88; N, 2.53. The enantiomers were separated
on the (R,R)-Beta-Gem column (100% hexane, 1.0 mL/min):
rt ) 2.9 (13.5%), 3.2 (86.5%). The elemental analysis data
were obtained for the racemic compound.
P r ep a r a tion of En a n tiom er ica lly En r ich ed (S)-2-Allyl-
1-(ter t-bu toxyca r bon yl)-7-ch lor oin d olin e (17). To a 0.03
M solution of indoline 12 (71.0 mg, 0.280 mmol) were added 2
(77 µL, 0.34 mmol, 0.07 M) and s-BuLi (0.26 mL, 1.3 M, 0.34
mmol) at -78 °C. Allyl bromide (36 µL, 0.42 mmol) was added,
and following chromatographic purification with 2.5-5%
EtOAc/hexane and preparative HPLC with 1% EtOAc/hexane,
17 (26 mg, 32%) was isolated as colorless oil: 1H NMR (CDCl3,
300 MHz) δ 7.18 (d, J ) 7.9 Hz, 1H), 7.07 (d, J ) 7.5 Hz, 1H),
6.95 (t, J ) 7.7 Hz, 1H), 5.85-5.64 (m, 1H), 5.07-5.02 (m, 2H),
4.61 (q, J ) 7.3 Hz, 1H), 3.35 (dd, J ) 8.5, 15.9 Hz, 1H), 2.59
(d, J ) 15.9 Hz, 1H), 2.39 (m, 1H), 2.21 (m, 1H), 1.53 (s, 9H);
13C NMR (CDCl3, 75 MHz) δ 153.1, 139.5, 135.7, 133.9, 128.9,
125.0, 124.2, 123.7, 117.6, 81.4, 62.0, 39.4, 34.2, 28.2. Anal.
Calcd for C16H20NO2Cl: C, 65.41; H, 6.86; N, 4.77. Found: C,
65.44; H, 6.76; N, 4.86. The enantiomers were separated on
the (S,S)-Whelk-O 1 column (2% IPA/hexane, 1.00 mL/min):
rt ) 6.1 (55%), 6.6 (45%).
P r ep a r a tion of En a n tiom er ica lly En r ich ed (R)-1-(ter t-
Bu toxycar bon yl)-7-ch lor o-2-(diph en ylh ydr oxym eth yl)in -
d olin e (14). To a 0.28 M solution of 2 (330 µL, 1.4 mmol)
and s-BuLi (1.07 mL, 1.35 M, 1.44 mmol) at -78 °C was added
a 0.06 M solution of 12 (304 mg, 1.20 mmol). A 0.36 M solution
of benzophenone in MTBE was added. Following the workup
and chromatographic purification with 5% EtOAc/hexane as
the eluent, indoline (R)-14 (403 mg, 77%) was isolated as a
white solid: mp 138-141 °C; [R]26 +78° (c 0.0046, CHCl3);
D
1H NMR (CDCl3, 300 MHz) δ 7.45-7.32 (m, 7H), 7.14-7.11
(m, 3H), 6.97 (t, J ) 4.5 Hz, 1H), 6.75 (d, J ) 4.9 Hz, 2H),
5.44 (dd, J ) 1.1, 9.4 Hz, 1H), 4.46 (br, 1H), 3.64 (dd, J )9.5,
16.6 Hz, 1H), 2.92 (d, J ) 16.8 Hz, 1H), 1.51 (s, 9H); 13C NMR
(CDCl3, 75 MHz) δ 155.0, 144.5, 141.7, 140.4, 135.5, 128.3,
127.9, 127.6, 127.3, 127.0, 124.9, 123.7, 121.9, 82.7, 80.7, 69.0,
33.4, 27.9. Anal. Calcd for C26H26NO3Cl: C, 71.63; H, 6.01;
N, 3.22. Found: C, 71.60; H, 6.02; N, 3.25. The enantiomers
were separated on the (S,S)-Whelk-O 1 column (5% IPA/
hexane, 1.25 mL/min): rt ) 6.7 (14%), 7.6 (86%). The
elemental analysis data were obtained for racemic material.
Recrystallization of 273 mg of (R)-14 from Et2O/pentane
yielded 177 mg (65%) of crystals: mp 145-147 °C. The er of
the product was determined to be 96:4 by HPLC. The crystals
of enriched (R)-14 were optically pure but were accompanied
by a small amount of racemic powder, which also crystallized
from the mother liquor.
Also isolated from this reaction were a colorless oil tenta-
tively identified as N-Boc-7-chloroindole (7.7 mg, 11%) and 12
(12.2 mg, 17%).
P r ep a r a tion of En a n tiom er ica lly En r ich ed (R)-1-(ter t-
Bu toxycar bon yl)-7-ch lor oin dolin e-2-car boxylic Acid (13).
To a 0.08 M solution of indoline 12 (95.4 mg, 0.376 mmol) at
-78 °C was added a 0.09 M precooled solution of 2 (104 µL,
0.451 mmol) and s-BuLi (0.34 mL, 1.3 M, 0.45 mmol). After
3.5 h, a stream of CO2 was passed through the flask for 0.5 h.
The solution was stirred at -78 °C for 3 h under a positive
pressure of CO2. The reaction was quenched with water, and
the aqueous solution was acidified to pH 2 with 10% HCl and
extracted with Et2O. Following chromatographic purification
with 10-50% MeOH/EtOAc, N-Boc-indoline-7-carboxylic acid
(3.1 mg, 3%) was obtained as a white solid,11a and (R)-13 (100.5
mg, 90%) was obtained as a white solid.
To indoline (R)-13 (76.9 mg, 0.258 mmol) in ethanol (10 mL)
was slowly added thionyl chloride (23 µL, 0.31 mmol) at -10
°C. The solution was allowed to stir at room temperature for
45 min and was then heated at 65 °C for 2 h. The thionyl
chloride was removed by successive additions of ethanol (3 ×
P r ep a r a tion of En a n tiom er ica lly En r ich ed (S)-1-(ter t-
Bu t oxyca r b on yl)-7-ch lor o-2-(t r im e t h ylst a n n yl)in d o-
lin e (15). To a 0.04 M solution of indoline 12 (102.1 mg, 0.402
(31) Hasan, I.; Marinelli, E. R.; Lin, L.-C. C.; Fowler, F. W.; Levy,
A. B. J . Org. Chem. 1981, 46, 157-164.